Sophion partners with Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, to enable standardized integration between Sophion APC platforms and Genedata Screener.
 "Kv1.3 current clamp assay developed on Qube 384 with Metrion Biosciences")
Kv1.3 current clamp assay developed on Qube 384 with Metrion Biosciences
New Sophion Bioscience application report highlights novel Kv1.3 current clamp assay to improve physiological read-out of drug effects.
 "Did you miss our webinar novel patch clamp assays to advance pain research?")
Did you miss our webinar novel patch clamp assays to advance pain research?
Talks by neuroscientist Reza Ghovanloo from Yale School of Medicine and Daniel Sauter from Sophion
 "Snake bite antidotes using engineered human antibodies discovered")
Snake bite antidotes using engineered human antibodies discovered
New research and paper discover and optimize a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakes.
 "How can we encourage more women to take leading positions in science?")
How can we encourage more women to take leading positions in science?
Females are underrepresented in leading positions in science and technology fields. Read Sandra Wilson’s story about when she became interested in science and has made it all the way to a leading position at Sophion Bioscience.
 "New software release for QPatch II available")
New software release for QPatch II available
Today, we launch the next software upgrade to QPatch ll, named Mars. With the new software suite, you can increase the output of your ion channel research even further.
 "World first: High throughput ion channel recordings of isolated primary dorsal root ganglion (DRG) neurons on Yale University’s Qube 384")
World first: High throughput ion channel recordings of isolated primary dorsal root ganglion (DRG) neurons on Yale University’s Qube 384
Ion channel recordings in isolated primary DRG neurons. New paper from Stephen Waxman‘s lab at Yale University. New paper from Stephen Waxman‘s lab at Yale University
 "Early career scientists can apply for research and travel grants from Sophion Bioscience")
Early career scientists can apply for research and travel grants from Sophion Bioscience
Scientists in the early stages of their careers are eligible for grants offered by Sophion Bioscience. Don’t miss the February opportunity to apply for our research and travels grants!
 "Developing iPSC ion channel recordings with automated patch clamp")
Developing iPSC ion channel recordings with automated patch clamp
Stem cells techniques pushing ion channel recordings in high throughput electrophysiology by Sophion scientists, collaborators, and users
 "Bruce Bean and Clifford Woolf Labs at Harvard Medical School Acquire QPatch Compact")
Bruce Bean and Clifford Woolf Labs at Harvard Medical School Acquire QPatch Compact
In support of their program developing novel treatments for pain, the Bruce Bean and Clifford Woolf labs at Harvard Medical School have acquired QPatch Compact
 "New video tutorials to help you get the best start with QPatch Compact")
New video tutorials to help you get the best start with QPatch Compact
New video tutorials and technical support documentation are available to help our customers adopt a best-practice workflow when working on QPatch Compact.
 "QPatch II secured the best infrastructure for Linköping University's new academic core facility")
QPatch II secured the best infrastructure for Linköping University's new academic core facility
Linköping University has installed Sophion's high-throughput automated patch clamp Patch II system at its national academic core facility for ion channel research.
 "Sophion technology helped Metrion Biosciences meet higher customer demands and growing assay complexity")
Sophion technology helped Metrion Biosciences meet higher customer demands and growing assay complexity
For Metrion Biosciences, access to automated patch clamp – and Sophion’s QPatch and Qube solutions – makes all the difference in their ability to undertake more complex, higher-capacity projects.
